Navigation Links
Study Suggests Repurposing Anti-depressant Medication to Target Medulloblastoma
Date:8/24/2014

CINCINNATI, Aug. 24, 2014 /PRNewswire-USNewswire/ -- An international research team reports in Nature Medicine a novel molecular pathway that causes an aggressive form of medulloblastoma, and suggests repurposing an anti-depressant medication to target the new pathway may help combat one of the most common brain cancers in children.

The multi-institutional group, led by scientists at Cancer and Blood Diseases Institute (CBDI) at Cincinnati Children's Hospital Medical Center, publish their results in the journal's online edition on Aug. 24. The researchers suggest their laboratory findings in mouse models of the disease could lead to a more targeted and effective molecular therapy that would also reduce the harmful side effects of current treatments, which include chemotherapy, radiation or surgery.

"Although current treatments improve survival rates, patients suffer severe side effects and relapse tumors carry mutations that resist treatment," said lead investigator Q. Richard Lu, Ph.D., scientific director of the Brain Tumor Center, part of the CBDI at Cincinnati Children's. "This underscores an urgent need for alternative targeted therapies, and we have identified a potent tumor suppressor that could help a subset of patients with an aggressive form of medulloblastoma."

Using genetically-engineered mice to model human medulloblastoma, the authors identified a gene called GNAS that encodes a protein called Gsα. Gsα kicks off a signaling cascade that researchers found suppresses the initiation of an aggressive form of medulloblastoma driven by a protein called Sonic hedgehog – considered one of the most important molecules in tissue formation and development.

The scientists used an anti-depressant medication called Rolipram – approved for behavioral therapy for use in Europe and Japan – to treat
'/>"/>

SOURCE Cincinnati Children's Hospital Medical Center
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
3. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
4. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
5. Shingles Vaccine is Safe, According to New Study
6. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
11. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... BEND, Ind. , Feb. 26, 2015  Mobility ... announce an agreement with Bank of America (NYSE: ... consumers nationwide to receive financing of the revolutionary MV-1 ... vehicle, designed from the ground up to provide safe ... Approved applicants can use their loan to purchase a ...
(Date:2/26/2015)... 26, 2015 LifeScienceIndustryResearch.com adds ... -In- Class Innovations and Cost Optimization Plays Major ... Pharmaceutical Companies research report to the pharmaceuticals intelligence ... this Global Pharma US & EU Outlook 2015 ... divestment of non-core assets result in healthy cash ...
(Date:2/26/2015)...  Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical ... virus infections, today announced that Jonathan P. ... of Finance, a newly created role.  Mr. Freve ... including financial planning and reporting, accounting and risk ... , President and CEO. Mr. ...
Breaking Medicine Technology:Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4Jonathan P. Freve, CPA, Joins Spring Bank Pharmaceuticals as Vice President of Finance 2
...  Every newborn baby should enter this world healthy.  The people ... to doing their best to make sure this happens.  That,s ... corporate sponsor of March of Dimes March for Babies, for ... awareness of infant health issues and educate doctors and mothers-to-be ...
... the law firm of LeClairRyan as a shareholder in ... firm,s Alexandria, Va. and Washington, D.C. offices. ... attorney will provide compliance, internal investigations and representation on ... the Foreign Corrupt Practices Act (FCPA) and the UK ...
Cached Medicine Technology:Mission Pharmacal Is Proud to Sponsor March for Babies® 2Mission Pharmacal Is Proud to Sponsor March for Babies® 3Veteran FCPA and White Collar Attorney Michael Volkov Joins LeClairRyan 2
(Date:2/27/2015)... Muscular Dystrophy Association research grantee Charles ... University, recently announced a potentially game-changing advance in ... Duchenne muscular dystrophy (DMD). The results were published ... discuss their implications at MDA's 2015 Scientific Conference, ... , Background: Gersbach and team are investigating ...
(Date:2/27/2015)... 27, 2015 According to the report, ... China Dental Industry in 2013 rose by 31.9%. However, ... amount of revenue generated by the industry was recorded ... registered by the industry in 2013. , View ... has identified the oral industry as a branch of ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 The ... Commuter Cities in Florida " report today. To ... the 2013 U.S. Census Bureau survey, considering only ... time of the survey. , The report visualizes ... methods of commuting and a breakdown of commute ...
(Date:2/27/2015)... 2015 On time and under budget, ... Hospital Joplin. Inside and out, the nearly 900,000-square-foot facility ... to replace the tornado-ravaged St. John’s Regional Medical Center ... is opening just 46 months after the tornado hit ... normally anticipate to plan, design and construct a similarly ...
(Date:2/27/2015)... The Radiology Business Management Association (RBMA) ... Fellows — one of the most highly regarded awards ... Since 2009, the RBMA Fellowship program has served to ... the Association and the profession. Fellow of the RBMA ... must meet a very high standard for educational accomplishment, ...
Breaking Medicine News(10 mins):Health News:Statement: New MDA-Funded Genetic Therapy Technique Targets DMD 2Health News:China Dental Industry to Expand Rapidly Owing to the Evolution of Medical and Healthcare Systems: MarketResearchReports.Biz 2Health News:China Dental Industry to Expand Rapidly Owing to the Evolution of Medical and Healthcare Systems: MarketResearchReports.Biz 3Health News:40 Best and Worst Commuter Cities in Florida Announced by Obrella 2Health News:New Hospital Built to Stand Against Nature 2Health News:New Hospital Built to Stand Against Nature 3Health News:New Hospital Built to Stand Against Nature 4Health News:RBMA Issues Call for Fellowship Applicants 2
... to expand GSK cardiovascular portfolio in US Acquisition ... provides sales, synergy ... /PRNewswire-,FirstCall/ -- GlaxoSmithKline (LSE: GSK) (NYSE: GSK ) and ... which Reliant will be acquired by GSK for $1.65 billion ...
... Give More Than $7.2 Million and Volunteer, Thousands of ... the Country, ABBOTT PARK, Ill., Nov. 21 ... their neighbors, providing more than,$7.2 million in support for ... These employee contributions from the,company,s annual giving campaign are ...
... often deadly among older American women, doctors too often ... new report by a team of vascular surgeons from ... College campuses of NewYork-Presbyterian Hospital. , Much of that ... research has focused almost exclusively on males, so in ...
... Partnership to Create Enhanced, Customized Computer-Aided Detection ... Technology for GE ... 21 ,iCAD(R), Inc. (Nasdaq: ICAD ), an industry-leading ... division of,GE (NYSE: GE ), a manufacturer of ...
... a Web-based program that tracks pharmacy doses from order entry ... ... 21 Baxa Corporation has signed a,strategic reseller agreement with MedKeeper to ... sales and distribution rights for all worldwide healthcare,markets for the MedKeeper software., ...
... Nov. 21 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS;,NASDAQ: ... written response from,the U.S. Food and Drug Administration ... for its once-daily tramadol formulation through,the Formal Dispute ... the Office of Drug Evaluation II, Center for ...
Cached Medicine News:Health News:GSK to Acquire Reliant Pharmaceuticals 2Health News:GSK to Acquire Reliant Pharmaceuticals 3Health News:GSK to Acquire Reliant Pharmaceuticals 4Health News:Abbott Employees Give Back to Local Communities This Holiday Season 2Health News:Abbott Employees Give Back to Local Communities This Holiday Season 3Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 2Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 3Health News:Arterial vascular disease underdiagnosed, undertreated in older US women 4Health News:GE Healthcare and iCAD enter into Developmental Agreement 2Health News:GE Healthcare and iCAD enter into Developmental Agreement 3Health News:GE Healthcare and iCAD enter into Developmental Agreement 4Health News:Baxa Corporation Signs Strategic Reseller Agreement With MedKeeper for Web-Based Productivity Tool 2Health News:Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: